Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
2) and antagonized the dopamine induction of [(35)S]GTPgammaS binding (pA2=9
AA92593 was used at 10 µM final concentration in various in vitro assays
Flow-injection MS/MS for gas-phase chiral recognition and enantiomeric quantitation of a novel boron-containing antibiotic (GSK2251052A) by the mass spectrometric kinetic method
inducing apoptosis
4 nM) and members of the VEGFR
Delamanid (OPC-67683) - CAS# 681492-22-8 60233 2) and antagonized the dopamineDelamanid (OPC 67683), CAS No. 681492 22 8, also known as OPC 67683, is a drug for the treatment of multi drug resistant tuberculosis. It works by blocking the synthesis of mycolic acids in Mycobacterium tuberculosis, the organism which causes tuberculosis, thus destabilising its cell wall. The drug is approved in the EU. Delamanid inhibits the synthesis of mycolic acids, crucial component of the cell wall of the Mycobacterium tuberculosis complex.